Predicting Drug Efficacy Using Integrative Models for Chronic Respiratory Diseases

E-ISSN： 2212-4055|12|2|124-131

ISSN： 1871-5281

Source： Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol.12, Iss.2, 2013-04, pp. : 124-131

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Using Drosophila models of neurodegenerative diseases for drug discovery

By Newman Tracey Sinadinos Christopher Johnston Alex Sealey Megan Mudher Amrit

Expert Opinion on Drug Discovery, Vol. 6, Iss. 2, 2011-02 ,pp. : 129-140

Informa Healthcare

Access to resources Recommend Favorite

Experimental models for predicting drug absorption and metabolism

By Alqahtani Saeed Mohamed Loqman A Kaddoumi Amal

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 10, 2013-10 ,pp. : 1241-1254

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and safety of letosteine in the treatment of sputum thickening and expectoration difficulty in patients with respiratory diseases: a multicenter, randomized, double-masked, double dummy, positive drug parallel controlled trial

Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol. 69, Iss. 11, 2014-11 ,pp. : 842-849

Govi-Verlag

Access to resources Recommend Favorite

The emerging utility of animal models of chronic neurodegenerative diseases

By Kahle P.J. Haass C.

Expert Opinion on Therapeutic Targets, Vol. 5, Iss. 1, 2001-02 ,pp. : 125-132

Informa Healthcare

Access to resources Recommend Favorite

Chronic Inflammatory Diseases and the Acute Respiratory Distress Syndrome (ARDS)

Current Pharmaceutical Design, Vol. 20, Iss. 9, 2014-03 ,pp. : 1400-1408

Bentham Science Publishers

Access to resources Recommend Favorite